Recursion Pharmaceuticals Inc Clas (RXRX)
SG&A Expense Growth
20.07%
Quarterly · Period ending:
RXRX SG&A Expense Growth
Latest reported20.07%period ending
Latest reported20.07%period ending
RXRX Quarterly SG&A Growth (QoQ) (0.00% → 20.07%)
Latest values, visible window
High-resolution chart · PNG
RXRX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 20.0688% | |
| 2.7751% | |
| -19.1482% | |
| -10.771% | |
| -14.6331% | |
| -29.197% | |
| 104.4283% | |
| 18.6096% | |
| 1.3532% | |
| 3.119% | |
| 4.3118% | |
| 3.2131% | |
| 23.6775% | |
| 15.304% | |
| 1.796% | |
| -8.0711% | |
| 0.5931% | |
| 9.7547% | |
| 22.3773% | |
| 13.2525% | |
| 55.0185% | |
| 17.9958% | |
| 8.7593% | |
| 34.9874% | |
| -7.2289% | |
| 0% |